Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer

Feasibility Study Using the Xoft Axxent Electronic Brachytherapy System for the Treatment of Endometrial Cancer

Multicenter, non-randomized, feasibility study to evaluate the treatment and assess acute safety of the FDA Cleared Axxent Electronic Brachytherapy System and vaginal applicator for intracavitary vaginal cuff treatment according to the physician's current standard of care.

Inclusion Criteria:

• Most types of endometrial (uterine) cancer Stage I and Stage II (see exclusion criteria below)
• Post hysterectomy

Exclusion Criteria:

• Endometrial (uterine) cancer Stage IA Grade 1
• Scleroderma
• Collagen vascular disease
• Active Lupus